Zobrazeno 1 - 10
of 73
pro vyhledávání: '"B I Korelitz"'
Publikováno v:
Gut. 54:1121-1125
Background: Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yi
Publikováno v:
Evidence-Based Gastroenterology. 6:17-19
Autor:
B I, Korelitz
Publikováno v:
The Mount Sinai journal of medicine, New York. 67(3)
Much of what we know about the role of immunopathologic mechanisms in causing Crohn's disease and ulcerative colitis originated from research at The Mount Sinai Hospital. The authors were privileged to have been able to share in this undertaking, alo
Autor:
J, Zlatanic, B I, Korelitz, N, Wisch, P, Kim, M, Ammirati, S, Schwarz, S, Gruenstein, L, Lipsey
Publikováno v:
The American journal of gastroenterology. 92(12)
Different hematologic abnormalities are often encountered in patients with inflammatory bowel disease. Among them anemia, leukocytosis, and thrombocytosis are commonly seen. Leukopenia and thrombocytopenia are observed mostly as a side effect of ther
Publikováno v:
The American journal of gastroenterology. 91(11)
A 39-yr-old white male with a prolonged history of Crohn's disease presented with worsening diarrhea associated with an increasingly painful rash of both lower extremities as well as left ankle swelling. A skin biopsy revealed an acute leukocytoclast
Autor:
B I, Korelitz, D H, Present
Publikováno v:
The Mount Sinai journal of medicine, New York. 63(3-4)
If the cause of Crohn's disease and ulcerative colitis turns out to be some immunopathologic mechanism, many of the steps leading to such an understanding of their pathogenesis can be attributed to concepts that originated at The Mount Sinai Hospital
Autor:
B I, Korelitz
Publikováno v:
The Gastroenterologist. 3(2)
I present the progressive development of treatment with immunosuppressive drugs for Crohn's disease and ulcerative colitis, starting with rationale, failure of corticosteroids for maintenance, early observations, controlled trials, collaborations, to
Autor:
T, Colonna, B I, Korelitz
Publikováno v:
The American journal of gastroenterology. 89(3)
1) to determine the frequency of induced leukopenia in patients with refractory Crohn's disease treated with 6-Mercaptopurine (6-MP). 2) to determine the influence of 6-MP-induced leukopenia on achieving remission [including the three major specific
Publikováno v:
The American journal of gastroenterology. 88(8)
We report our observations after 20 yr of clinical experience with 6-mercaptopurine (6-MP) in 148 patients with Crohn's disease who had not satisfactorily responded to steroids and other drugs. Specific therapeutic goals were established for each pat
Autor:
R A, Mendelsohn, B I, Korelitz
Publikováno v:
The American journal of gastroenterology. 88(1)
We present a case of a patient who had documented ulcerative colitis as a child and later presented with isolated Crohn's jejunitis. Although rare, Crohn's disease must be considered in those patients with segmental inflammation of the small bowel an